Quick Takeaways
- BeOne Medicines Ltd. has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $20,943,045.
- Recent insider filing activity is available below.
Insider Trading & Ownership of BeOne Medicines Ltd.
- Location
- Basel
- Summary
- The estimated value of insider holdings of BeOne Medicines Ltd. is at least $20,943,045 dollars as of 28 Sep 2021. BeOne Medicines Ltd. is the 10%+ Owner of LEAP THERAPEUTICS, INC. and owns shares of CYPHERPUNK TECHNOLOGIES INC. (CYPH) stock worth about $20.94M.
- Signature
- BeiGene, Ltd. /s/ Scott A. Samuels, SVP, General Counsel
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow BeOne Medicines Ltd. and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: LEAP THERAPEUTICS, INC. ($20,943,045).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of BeOne Medicines Ltd.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CYPH | LEAP THERAPEUTICS, INC. | 10%+ Owner | $20,943,045 | 24 Sep 2021 |
Insider Transactions Reported by BeOne Medicines Ltd.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.